PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

Hall, Tracilyn

150
PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

Sunday, March 29, 2015: 3:05 PM

Salon C-D (Hilton Chicago)

T. R. Hall¹, C. M. DiGloria², M. Kim², L. Zhang², R. Foster², W. B. Growdon¹ and B. R. Rueda²
¹Massachusetts General Hospital/Harvard University, Boston, MA, ²Massachusetts General Hospital, Boston, MA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

150
PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

150 PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

150
PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts